nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—Fluoxymesterone—Mometasone—systemic scleroderma	0.137	0.182	CrCrCtD
Eplerenone—Fludrocortisone—Mometasone—systemic scleroderma	0.133	0.177	CrCrCtD
Eplerenone—Hydrocortisone—Mometasone—systemic scleroderma	0.109	0.145	CrCrCtD
Eplerenone—Hydrocortamate—Prednisone—systemic scleroderma	0.0863	0.115	CrCrCtD
Eplerenone—Cortisone acetate—Prednisone—systemic scleroderma	0.0836	0.111	CrCrCtD
Eplerenone—Fludrocortisone—Prednisone—systemic scleroderma	0.0726	0.0967	CrCrCtD
Eplerenone—Methyltestosterone—Prednisone—systemic scleroderma	0.0708	0.0943	CrCrCtD
Eplerenone—Hydrocortisone—Prednisone—systemic scleroderma	0.0592	0.0788	CrCrCtD
Eplerenone—Diarrhoea—Mometasone—systemic scleroderma	0.000284	0.00114	CcSEcCtD
Eplerenone—Hypokalaemia—Prednisone—systemic scleroderma	0.000284	0.00114	CcSEcCtD
Eplerenone—Syncope—Lisinopril—systemic scleroderma	0.000283	0.00114	CcSEcCtD
Eplerenone—Shock—Mycophenolic acid—systemic scleroderma	0.000282	0.00113	CcSEcCtD
Eplerenone—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000281	0.00113	CcSEcCtD
Eplerenone—Hypotension—Leflunomide—systemic scleroderma	0.000281	0.00113	CcSEcCtD
Eplerenone—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000279	0.00112	CcSEcCtD
Eplerenone—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000278	0.00112	CcSEcCtD
Eplerenone—Loss of consciousness—Lisinopril—systemic scleroderma	0.000278	0.00112	CcSEcCtD
Eplerenone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00111	CcSEcCtD
Eplerenone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000277	0.00111	CcSEcCtD
Eplerenone—Cough—Lisinopril—systemic scleroderma	0.000276	0.00111	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000275	0.00111	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000274	0.0011	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000273	0.0011	CcSEcCtD
Eplerenone—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000273	0.0011	CcSEcCtD
Eplerenone—Insomnia—Leflunomide—systemic scleroderma	0.000272	0.00109	CcSEcCtD
Eplerenone—Chest pain—Lisinopril—systemic scleroderma	0.000269	0.00108	CcSEcCtD
Eplerenone—Myalgia—Lisinopril—systemic scleroderma	0.000269	0.00108	CcSEcCtD
Eplerenone—Arthralgia—Lisinopril—systemic scleroderma	0.000269	0.00108	CcSEcCtD
Eplerenone—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00108	CcSEcCtD
Eplerenone—Dyspnoea—Leflunomide—systemic scleroderma	0.000268	0.00108	CcSEcCtD
Eplerenone—Hypotension—Mycophenolic acid—systemic scleroderma	0.000268	0.00108	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000267	0.00107	CcSEcCtD
Eplerenone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000266	0.00107	CcSEcCtD
Eplerenone—Discomfort—Lisinopril—systemic scleroderma	0.000266	0.00107	CcSEcCtD
Eplerenone—Dyspepsia—Leflunomide—systemic scleroderma	0.000264	0.00106	CcSEcCtD
Eplerenone—Vomiting—Mometasone—systemic scleroderma	0.000264	0.00106	CcSEcCtD
Eplerenone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000262	0.00105	CcSEcCtD
Eplerenone—Rash—Mometasone—systemic scleroderma	0.000261	0.00105	CcSEcCtD
Eplerenone—Asthenia—Captopril—systemic scleroderma	0.000261	0.00105	CcSEcCtD
Eplerenone—Dermatitis—Mometasone—systemic scleroderma	0.000261	0.00105	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000261	0.00105	CcSEcCtD
Eplerenone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00026	0.00104	CcSEcCtD
Eplerenone—Headache—Mometasone—systemic scleroderma	0.00026	0.00104	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000259	0.00104	CcSEcCtD
Eplerenone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000259	0.00104	CcSEcCtD
Eplerenone—Fatigue—Leflunomide—systemic scleroderma	0.000259	0.00104	CcSEcCtD
Eplerenone—Pruritus—Captopril—systemic scleroderma	0.000258	0.00104	CcSEcCtD
Eplerenone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000257	0.00103	CcSEcCtD
Eplerenone—Constipation—Leflunomide—systemic scleroderma	0.000257	0.00103	CcSEcCtD
Eplerenone—Pain—Leflunomide—systemic scleroderma	0.000257	0.00103	CcSEcCtD
Eplerenone—Infection—Lisinopril—systemic scleroderma	0.000256	0.00103	CcSEcCtD
Eplerenone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00103	CcSEcCtD
Eplerenone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000255	0.00103	CcSEcCtD
Eplerenone—Shock—Lisinopril—systemic scleroderma	0.000254	0.00102	CcSEcCtD
Eplerenone—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00102	CcSEcCtD
Eplerenone—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000252	0.00101	CcSEcCtD
Eplerenone—Abdominal pain—Azathioprine—systemic scleroderma	0.000251	0.00101	CcSEcCtD
Eplerenone—Body temperature increased—Azathioprine—systemic scleroderma	0.000251	0.00101	CcSEcCtD
Eplerenone—Skin disorder—Lisinopril—systemic scleroderma	0.000251	0.00101	CcSEcCtD
Eplerenone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00025	0.001	CcSEcCtD
Eplerenone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000249	0.001	CcSEcCtD
Eplerenone—Diarrhoea—Captopril—systemic scleroderma	0.000249	0.001	CcSEcCtD
Eplerenone—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000998	CcSEcCtD
Eplerenone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000247	0.000994	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000247	0.000994	CcSEcCtD
Eplerenone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000247	0.000993	CcSEcCtD
Eplerenone—Nausea—Mometasone—systemic scleroderma	0.000246	0.00099	CcSEcCtD
Eplerenone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000245	0.000987	CcSEcCtD
Eplerenone—Pain—Mycophenolic acid—systemic scleroderma	0.000245	0.000984	CcSEcCtD
Eplerenone—Constipation—Mycophenolic acid—systemic scleroderma	0.000245	0.000984	CcSEcCtD
Eplerenone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000978	CcSEcCtD
Eplerenone—Hyperglycaemia—Prednisone—systemic scleroderma	0.000243	0.000977	CcSEcCtD
Eplerenone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000971	CcSEcCtD
Eplerenone—Hypotension—Lisinopril—systemic scleroderma	0.000241	0.000969	CcSEcCtD
Eplerenone—Dizziness—Captopril—systemic scleroderma	0.000241	0.000968	CcSEcCtD
Eplerenone—Depression—Prednisone—systemic scleroderma	0.00024	0.000963	CcSEcCtD
Eplerenone—Body temperature increased—Leflunomide—systemic scleroderma	0.000237	0.000954	CcSEcCtD
Eplerenone—Abdominal pain—Leflunomide—systemic scleroderma	0.000237	0.000954	CcSEcCtD
Eplerenone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000237	0.000952	CcSEcCtD
Eplerenone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000236	0.000949	CcSEcCtD
Eplerenone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000948	CcSEcCtD
Eplerenone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000948	CcSEcCtD
Eplerenone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000948	CcSEcCtD
Eplerenone—Myocardial infarction—Prednisone—systemic scleroderma	0.000235	0.000947	CcSEcCtD
Eplerenone—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000235	0.000947	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000235	0.000945	CcSEcCtD
Eplerenone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000234	0.000941	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000941	CcSEcCtD
Eplerenone—Insomnia—Lisinopril—systemic scleroderma	0.000233	0.000938	CcSEcCtD
Eplerenone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000936	CcSEcCtD
Eplerenone—Vomiting—Captopril—systemic scleroderma	0.000232	0.000931	CcSEcCtD
Eplerenone—Dyspnoea—Lisinopril—systemic scleroderma	0.00023	0.000924	CcSEcCtD
Eplerenone—Rash—Captopril—systemic scleroderma	0.00023	0.000923	CcSEcCtD
Eplerenone—Dermatitis—Captopril—systemic scleroderma	0.000229	0.000922	CcSEcCtD
Eplerenone—Headache—Captopril—systemic scleroderma	0.000228	0.000917	CcSEcCtD
Eplerenone—Dyspepsia—Lisinopril—systemic scleroderma	0.000227	0.000913	CcSEcCtD
Eplerenone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000226	0.00091	CcSEcCtD
Eplerenone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000226	0.00091	CcSEcCtD
Eplerenone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000903	CcSEcCtD
Eplerenone—Eosinophilia—Methotrexate—systemic scleroderma	0.000223	0.000896	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000223	0.000895	CcSEcCtD
Eplerenone—Fatigue—Lisinopril—systemic scleroderma	0.000222	0.000894	CcSEcCtD
Eplerenone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000894	CcSEcCtD
Eplerenone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000891	CcSEcCtD
Eplerenone—Pain—Lisinopril—systemic scleroderma	0.000221	0.000887	CcSEcCtD
Eplerenone—Constipation—Lisinopril—systemic scleroderma	0.000221	0.000887	CcSEcCtD
Eplerenone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000882	CcSEcCtD
Eplerenone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000878	CcSEcCtD
Eplerenone—Diarrhoea—Azathioprine—systemic scleroderma	0.000217	0.000874	CcSEcCtD
Eplerenone—Nausea—Captopril—systemic scleroderma	0.000216	0.00087	CcSEcCtD
Eplerenone—Asthenia—Leflunomide—systemic scleroderma	0.000215	0.000866	CcSEcCtD
Eplerenone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000213	0.000854	CcSEcCtD
Eplerenone—Pruritus—Leflunomide—systemic scleroderma	0.000212	0.000854	CcSEcCtD
Eplerenone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000212	0.000852	CcSEcCtD
Eplerenone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000849	CcSEcCtD
Eplerenone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000211	0.000848	CcSEcCtD
Eplerenone—Dizziness—Azathioprine—systemic scleroderma	0.00021	0.000845	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000209	0.000841	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000828	CcSEcCtD
Eplerenone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000205	0.000826	CcSEcCtD
Eplerenone—Diarrhoea—Leflunomide—systemic scleroderma	0.000205	0.000826	CcSEcCtD
Eplerenone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000822	CcSEcCtD
Eplerenone—Body temperature increased—Lisinopril—systemic scleroderma	0.000204	0.00082	CcSEcCtD
Eplerenone—Abdominal pain—Lisinopril—systemic scleroderma	0.000204	0.00082	CcSEcCtD
Eplerenone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000203	0.000814	CcSEcCtD
Eplerenone—Vomiting—Azathioprine—systemic scleroderma	0.000202	0.000812	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—systemic scleroderma	0.000202	0.000812	CcSEcCtD
Eplerenone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00081	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—systemic scleroderma	0.000201	0.000807	CcSEcCtD
Eplerenone—Infestation—Methotrexate—systemic scleroderma	0.000201	0.000807	CcSEcCtD
Eplerenone—Rash—Azathioprine—systemic scleroderma	0.0002	0.000806	CcSEcCtD
Eplerenone—Dermatitis—Azathioprine—systemic scleroderma	0.0002	0.000805	CcSEcCtD
Eplerenone—Depression—Methotrexate—systemic scleroderma	0.0002	0.000805	CcSEcCtD
Eplerenone—Flushing—Prednisone—systemic scleroderma	0.0002	0.000804	CcSEcCtD
Eplerenone—Headache—Azathioprine—systemic scleroderma	0.000199	0.000801	CcSEcCtD
Eplerenone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000199	0.0008	CcSEcCtD
Eplerenone—Dizziness—Leflunomide—systemic scleroderma	0.000199	0.000798	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—systemic scleroderma	0.000197	0.000793	CcSEcCtD
Eplerenone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000196	0.000788	CcSEcCtD
Eplerenone—Angiopathy—Prednisone—systemic scleroderma	0.000196	0.000786	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000784	CcSEcCtD
Eplerenone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000777	CcSEcCtD
Eplerenone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000777	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—systemic scleroderma	0.000191	0.000769	CcSEcCtD
Eplerenone—Vomiting—Leflunomide—systemic scleroderma	0.000191	0.000767	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00019	0.000763	CcSEcCtD
Eplerenone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000189	0.000761	CcSEcCtD
Eplerenone—Rash—Leflunomide—systemic scleroderma	0.000189	0.000761	CcSEcCtD
Eplerenone—Dermatitis—Leflunomide—systemic scleroderma	0.000189	0.00076	CcSEcCtD
Eplerenone—Mental disorder—Prednisone—systemic scleroderma	0.000189	0.000759	CcSEcCtD
Eplerenone—Nausea—Azathioprine—systemic scleroderma	0.000189	0.000759	CcSEcCtD
Eplerenone—Headache—Leflunomide—systemic scleroderma	0.000188	0.000756	CcSEcCtD
Eplerenone—Malnutrition—Prednisone—systemic scleroderma	0.000188	0.000755	CcSEcCtD
Eplerenone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000749	CcSEcCtD
Eplerenone—Asthenia—Lisinopril—systemic scleroderma	0.000185	0.000744	CcSEcCtD
Eplerenone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000743	CcSEcCtD
Eplerenone—Pruritus—Lisinopril—systemic scleroderma	0.000182	0.000734	CcSEcCtD
Eplerenone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000182	0.000732	CcSEcCtD
Eplerenone—Rash—Mycophenolic acid—systemic scleroderma	0.000181	0.000726	CcSEcCtD
Eplerenone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00018	0.000725	CcSEcCtD
Eplerenone—Headache—Mycophenolic acid—systemic scleroderma	0.000179	0.000721	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—systemic scleroderma	0.000179	0.000719	CcSEcCtD
Eplerenone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000718	CcSEcCtD
Eplerenone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000718	CcSEcCtD
Eplerenone—Nausea—Leflunomide—systemic scleroderma	0.000178	0.000717	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000178	0.000715	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—systemic scleroderma	0.000177	0.00071	CcSEcCtD
Eplerenone—Diarrhoea—Lisinopril—systemic scleroderma	0.000176	0.000709	CcSEcCtD
Eplerenone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000174	0.0007	CcSEcCtD
Eplerenone—Anaemia—Prednisone—systemic scleroderma	0.000173	0.000697	CcSEcCtD
Eplerenone—Angioedema—Prednisone—systemic scleroderma	0.000172	0.000689	CcSEcCtD
Eplerenone—Dizziness—Lisinopril—systemic scleroderma	0.000171	0.000686	CcSEcCtD
Eplerenone—Nausea—Mycophenolic acid—systemic scleroderma	0.00017	0.000684	CcSEcCtD
Eplerenone—Malaise—Prednisone—systemic scleroderma	0.000169	0.00068	CcSEcCtD
Eplerenone—Syncope—Prednisone—systemic scleroderma	0.000168	0.000677	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—systemic scleroderma	0.000168	0.000675	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000167	0.000672	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisone—systemic scleroderma	0.000165	0.000663	CcSEcCtD
Eplerenone—Vomiting—Lisinopril—systemic scleroderma	0.000164	0.000659	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—systemic scleroderma	0.000163	0.000657	CcSEcCtD
Eplerenone—Rash—Lisinopril—systemic scleroderma	0.000163	0.000654	CcSEcCtD
Eplerenone—Dermatitis—Lisinopril—systemic scleroderma	0.000162	0.000653	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000162	0.000653	CcSEcCtD
Eplerenone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000652	CcSEcCtD
Eplerenone—Headache—Lisinopril—systemic scleroderma	0.000162	0.00065	CcSEcCtD
Eplerenone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000643	CcSEcCtD
Eplerenone—Myalgia—Prednisone—systemic scleroderma	0.00016	0.000642	CcSEcCtD
Eplerenone—Arthralgia—Prednisone—systemic scleroderma	0.00016	0.000642	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000159	0.000638	CcSEcCtD
Eplerenone—Discomfort—Prednisone—systemic scleroderma	0.000158	0.000635	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—systemic scleroderma	0.000158	0.000635	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—systemic scleroderma	0.000157	0.000631	CcSEcCtD
Eplerenone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000622	CcSEcCtD
Eplerenone—Nausea—Lisinopril—systemic scleroderma	0.000153	0.000616	CcSEcCtD
Eplerenone—Infection—Prednisone—systemic scleroderma	0.000152	0.000612	CcSEcCtD
Eplerenone—Back pain—Methotrexate—systemic scleroderma	0.000152	0.00061	CcSEcCtD
Eplerenone—Shock—Prednisone—systemic scleroderma	0.000151	0.000606	CcSEcCtD
Eplerenone—Nervous system disorder—Prednisone—systemic scleroderma	0.00015	0.000604	CcSEcCtD
Eplerenone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000601	CcSEcCtD
Eplerenone—Skin disorder—Prednisone—systemic scleroderma	0.000149	0.000598	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000148	0.000595	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000146	0.000585	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—systemic scleroderma	0.000145	0.000583	CcSEcCtD
Eplerenone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000578	CcSEcCtD
Eplerenone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000573	CcSEcCtD
Eplerenone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000572	CcSEcCtD
Eplerenone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000569	CcSEcCtD
Eplerenone—Malaise—Methotrexate—systemic scleroderma	0.000141	0.000569	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00014	0.000561	CcSEcCtD
Eplerenone—Insomnia—Prednisone—systemic scleroderma	0.000139	0.000557	CcSEcCtD
Eplerenone—Cough—Methotrexate—systemic scleroderma	0.000137	0.00055	CcSEcCtD
Eplerenone—Dyspepsia—Prednisone—systemic scleroderma	0.000135	0.000542	CcSEcCtD
Eplerenone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000134	0.00054	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—systemic scleroderma	0.000134	0.000537	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—systemic scleroderma	0.000134	0.000537	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—systemic scleroderma	0.000134	0.000537	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000133	0.000533	CcSEcCtD
Eplerenone—Fatigue—Prednisone—systemic scleroderma	0.000132	0.000531	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—systemic scleroderma	0.000132	0.00053	CcSEcCtD
Eplerenone—Constipation—Prednisone—systemic scleroderma	0.000131	0.000527	CcSEcCtD
Eplerenone—Infection—Methotrexate—systemic scleroderma	0.000127	0.000511	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisone—systemic scleroderma	0.000126	0.000507	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000126	0.000505	CcSEcCtD
Eplerenone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000125	0.000504	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—systemic scleroderma	0.000124	0.0005	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000124	0.000498	CcSEcCtD
Eplerenone—Body temperature increased—Prednisone—systemic scleroderma	0.000121	0.000487	CcSEcCtD
Eplerenone—Abdominal pain—Prednisone—systemic scleroderma	0.000121	0.000487	CcSEcCtD
Eplerenone—Hypotension—Methotrexate—systemic scleroderma	0.00012	0.000481	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000117	0.000469	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—systemic scleroderma	0.000116	0.000466	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—systemic scleroderma	0.000114	0.000459	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—systemic scleroderma	0.000113	0.000453	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000111	0.000444	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—systemic scleroderma	0.00011	0.000444	CcSEcCtD
Eplerenone—Asthenia—Prednisone—systemic scleroderma	0.00011	0.000442	CcSEcCtD
Eplerenone—Pain—Methotrexate—systemic scleroderma	0.000109	0.00044	CcSEcCtD
Eplerenone—Pruritus—Prednisone—systemic scleroderma	0.000108	0.000436	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000106	0.000424	CcSEcCtD
Eplerenone—Diarrhoea—Prednisone—systemic scleroderma	0.000105	0.000421	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000105	0.000421	CcSEcCtD
Eplerenone—Dizziness—Prednisone—systemic scleroderma	0.000101	0.000407	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—systemic scleroderma	0.000101	0.000407	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—systemic scleroderma	0.000101	0.000407	CcSEcCtD
Eplerenone—Vomiting—Prednisone—systemic scleroderma	9.74e-05	0.000392	CcSEcCtD
Eplerenone—Rash—Prednisone—systemic scleroderma	9.66e-05	0.000388	CcSEcCtD
Eplerenone—Dermatitis—Prednisone—systemic scleroderma	9.65e-05	0.000388	CcSEcCtD
Eplerenone—Headache—Prednisone—systemic scleroderma	9.6e-05	0.000386	CcSEcCtD
Eplerenone—Asthenia—Methotrexate—systemic scleroderma	9.19e-05	0.000369	CcSEcCtD
Eplerenone—Nausea—Prednisone—systemic scleroderma	9.1e-05	0.000366	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—systemic scleroderma	9.06e-05	0.000364	CcSEcCtD
Eplerenone—Diarrhoea—Methotrexate—systemic scleroderma	8.76e-05	0.000352	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—systemic scleroderma	8.47e-05	0.00034	CcSEcCtD
Eplerenone—Vomiting—Methotrexate—systemic scleroderma	8.14e-05	0.000327	CcSEcCtD
Eplerenone—Rash—Methotrexate—systemic scleroderma	8.07e-05	0.000325	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—systemic scleroderma	8.06e-05	0.000324	CcSEcCtD
Eplerenone—Headache—Methotrexate—systemic scleroderma	8.02e-05	0.000322	CcSEcCtD
Eplerenone—Nausea—Methotrexate—systemic scleroderma	7.6e-05	0.000306	CcSEcCtD
